Magnetic resonance imaging of solitary brain metastases: Main findings of nonmorphological sequences;La risonanza magnetica delle metastasi cerebrali solitarie: definizione dei reperti più significativi delle tecniche non morfologiche

Radiologia Medica

Volumn 117, Issue 7, 2012, Pages 1225-1241

  Gaudino, S ^a   Di Lella, G M ^a   Russo, R ^a   Lo Russo, V S ^a   Piludu, F ^a   Quaglio, F R ^a   Gualano, M R ^b   De Waure, C ^b   Colosimo, C ^a  

^a Istituto di Radiologia di Universita Cattolica del Sacro Cuore di Roma   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

Brain neoplasms; DWI; MR spectroscopy; PWI; Solitary metastasis

Indexed keywords

ASPARTIC ACID; CHOLINE; CONTRAST MEDIUM; CREATINE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; GADOBENIC ACID; LIPID; MEGLUMINE; N ACETYLASPARTIC ACID; N-ACETYLASPARTATE; ORGANOMETALLIC COMPOUND;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; BLOOD VOLUME; BRAIN TUMOR; CHILD; DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; MALE; METABOLISM; METASTASIS; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ASPARTIC ACID; BLOOD VOLUME; BRAIN NEOPLASMS; CHILD; CHOLINE; CONTRAST MEDIA; CREATINE; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; LIPIDS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MEGLUMINE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS;

EID: 84867863261     PISSN: 00338362     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11547-012-0846-2     Document Type: Article

References (39)

1. Nathoo N, Toms SA, Barnett GH (2004) Metastases to the brain: current management perspectives. Expert Rev Neurother 4:633-640 (Pubitemid 38890591)
2. Barnholtz-Sloan JS, Sloan AE, Davis FG et al (2004) Incidence proportions of brain metastases in patients diagnosed (1973-2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol 22:2865-2872 (Pubitemid 41079905)
3. Gavrilovic IT, Posner JB (2005) Brain metastases: epidemiology and pathophysiology. J Neurooncol 75:5-14 (Pubitemid 41548673)
4. Kamar FG, Posner JB (2010) Brain metastases. Semin Neurol 30:217-235
5. Posner JB, Chernik NL (1978) Intracranial metastases from systemic cancer. Adv Neurol 19:579-592
6. Le Chevalier T, Smith FP, Caille P (1985) Sites of primary malignancies in patients presenting with cerebral metastases: a review of 120 cases. Cancer 56:880-882 (Pubitemid 15228285)
7. Kehrli P (1999) Epidemiology of brain metastases. Neurochirurgie 45:357-363 (Pubitemid 30158732)
8. Harrison LE, Brennan MF, Newman E et al (1997) Hepatic resection for noncolorectal, non-neuroendocrine metastases: a fifteen-year experience with ninety-six patients. Surgery 121:625-632 (Pubitemid 27251901)
9. Larson DA, Rubenstrein JL, McDermott MW (2005) Metasatic brain cancer. In: DeVita VT, Hellman S, Rosenberg SA (eds). Cancer, principles & practice of oncology. Lippincott Williams & Wilkins, Philadelphia, PA, pp 2328-2343
10. Jung S, Kim HW, Lee JH et al (2002) Brain tumor invasion model system using organotypic brain-slice culture as an alternative to in vivo model. J Cancer Res Clin Oncol 128:269-476
11. Falini A, Giovanna C, Origgi D et al (1996) Proton magnetic spectroscopy and intracranial tumors: clinical perspectives. J Neurology 243:706-714 (Pubitemid 26371927)
12. Sijens PE, Knopp MV, Brunetti A et al (1995) 1H MR spectroscopy in patients with metastatic brain tumors: a multicenter study. Magn Reson Med 33:818-826
13. Poptani H, Gupta RK, Roy R et al (1995) Characterization of intracranial mass lesions with in vivo proton MR spectroscopy. AJNR Am J Neuroradiol 16:1593-1603
14. De Edelenyi FS, Rubin C, Esteve F et al (2000) A new approach for analyzing proton magnetic resonance spectroscopic images of brain tumors: nosologic images. Nat Med 6:1287-1289
15. Law M, Cha S, Knopp EA et al (2002) High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging. Radiology 222:715-721 (Pubitemid 34215219)
16. Brem SS, Bierman PJ, Brem H et al (2011) Central nervous system cancers. J Natl Compr Canc Netw 9:352-400
17. Niwińska A, Tacikowska M, Murawska M (2010) The effect of early detection of occult brain metastases in HER2-positive breast cancer patients on survival and cause of death. Int J Radiat Oncol Biol Phys 77:1134-1139
18. Oshiro S, Tsugu H, Komatsu F et al (2008) Metastatic adenocarcinoma in the brain: magnetic resonance imaging with pathological correlations to mucin content. Anticancer Res 28:407-413 (Pubitemid 351362845)
19. Isiklar I, Leeds NE, Fuller GN, Kumar AJ (1995) Intracranial metastatic melanoma: correlation between MR imaging characteristics and melanin content. AJR Am J Roentgenol 165:1503-1512
20. Law M (2009) Advanced imaging techniques in brain tumors. Cancer Imaging 9(Spec No A):S4-S9
21. Hayashida Y, Hirai T, Morishita S et al (2006) Diffusion-weighted imaging of metastatic brain tumors: comparison with histologic type and tumor cellularity. AJNR Am J Neuroradiol 27:1419-1425 (Pubitemid 44260120)
22. Duygulu G, Ovali GY, Calli C et al (2010) Intracerebral metastasis showing restricted diffusion: correlation with histopathologic findings. Eur J Radiol 4:117-120
23. Server A, Kulle B, Maehlen J (2009) Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema. Acta Radiol 50:682-689
24. Rizzo L, Crasto SG, Moruno PG (2009) Role of diffusion- and perfusionweighted MR imaging for brain tumour characterisation. Radiol Med 114:645-659
25. Bink A, Gaa J, Franz K et al (2005) Importance of diffusion-weighted imaging in the diagnosis of cystic brain tumors and intracerebral abscesses. Zentralbl Neurochir 66:119-125 (Pubitemid 41197112)
26. Wetzel SG, Cha S, Johnson G et al (2002) Relative cerebral blood volume measurements in intracranial mass lesions: interobserver and intraobserver reproducibility study. Radiology 224:797-803 (Pubitemid 34919816)
27. Sorensen AG, Reimer P (2001) Imaging RM di perfusione cerebrale. Principi ed applicazioni correnti. CIC Edizioni Internazionali, Roma
28. Boxerman JL, Schmainda KM, Weisskoff RM (2006) Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. AJNR Am J Neuroradiol 27:859-867 (Pubitemid 44897737)
29. Uematsu H, Maeda M (2006) Double echo perfusion-weighted MR imaging: basic concepts and application in brain tumors for the assessment of tumor blood volume and vascular permeability. Eur Radiol 16:180-186 (Pubitemid 43103583)
30. Chan JH, Tsui EY, Chau LF (2002) Discrimination of an infected brain tumor from a cerebral abscess by combined MR perfusion and diffusion imaging. Comput Med Imaging Graph 26:19-23 (Pubitemid 33081097)
31. Cha S, Knopp EA, Johnson G et al (2002) Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology 223:11-29 (Pubitemid 34258186)
32. Hakyemez B, Erdogan C, Bolca N et al (2006) Evaluation of different cerebral mass lesions by perfusion-weighted MR imaging. J Magn Reson Imaging 24:817-824 (Pubitemid 44549984)
33. Zonari P, Baraldi P, Crisi G (2007) Multimodal MRI in the characterization of glial neoplasms: the combined role of single-voxel MR spectroscopy, diffusion imaging and echo-planar perfusion imaging. Neuroradiology 49:795-803 (Pubitemid 47497767)
34. Mangla R, Kolar B, Zhu T et al (2011) Percentage signal recovery derived from MR dynamic susceptibility contrast imaging is useful to differentiate common enhancing malignant lesions of the brain. AJNR Am J Neuroradiol 32:1004-1010
35. Hossman KA, Blöink M (1981) Blood flow and regulation of blood flow in experimental peritumoral edema. Stroke 12:211-217 (Pubitemid 11113181)
36. Uematsu H, Maeda M, Itoh H (2003) Peritumoral brain edema in intracranial meningiomas evaluated by dynamic perfusion-weighted MR imaging: a preliminary study. Eur Radiol 13:758-762 (Pubitemid 36790558)
37. Wang S, Kim S, Chawla S et al (2011) Differentiation between glioblastomas, solitary brain metastases, and primary cerebral lymphomas using diffusion tensor and dynamic susceptibility contrast-enhanced MR imaging. AJNR Am J Neuroradiol 32:507-514
38. Server A, Orheim TE, Graff BA et al (2011) Diagnostic examination performance by using microvascular leakage, cerebral blood volume, and blood flow derived from 3-T dynamic susceptibility-weighted contrastenhanced perfusion MR imaging in the differentiation of glioblastoma multiforme and brain metastasis. Neuroradiology 53:319-330
39. Chawla S, Zhang Y, Wang S et al (2010) Proton magnetic resonance spectroscopy in differentiating glioblastomas from primary cerebral lymphomas and brain metastases. J Comput Assist Tomogr 34:836-841